{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:07:44Z","timestamp":1759057664733},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jviromet.2008.03.025","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T08:56:43Z","timestamp":1211273803000},"page":"66-73","source":"Crossref","is-referenced-by-count":20,"title":["Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus"],"prefix":"10.1016","volume":"151","author":[{"given":"Fabiana","family":"Dal Pozzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2008.03.025_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.antiviral.2003.10.003","article-title":"In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?","volume":"61","author":"Andrei","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2008.03.025_bib2","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JVI.02746-06","article-title":"Development of Sindbis viruses encoding nsP2\/GFP chimeric proteins and their application for studying nsP2 functioning","volume":"81","author":"Atasheva","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib3","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","article-title":"New class of orthopoxvirus antiviral drugs that block viral maturation","volume":"78","author":"Byrd","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib4","first-page":"177","article-title":"Cytomegalovirus infection in patients with solid-organ transplant. Recently reviewed immunologic response and pathogenicity mechanisms","volume":"43","author":"Caltenco-Serrano","year":"2001","journal-title":"Rev. Latinoam. Microbiol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CDLI.11.2.406-410.2004","article-title":"Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus","volume":"11","author":"Cosma","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1124\/mol.104.010249","article-title":"A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors","volume":"67","author":"Daelemans","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2008.03.025_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/NCN-200059772","article-title":"Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines","volume":"24","author":"De Clercq","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.jviromet.2008.03.025_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00001813-199508000-00005","article-title":"Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays","volume":"6","author":"Dengler","year":"1995","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jviromet.2008.03.025_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0042-6822(03)00195-8","article-title":"Rhesus monkey rhadinovirus (RRV): construction of a RRV-GFP recombinant virus and development of assays to assess viral replication","volume":"20","author":"DeWire","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2008.03.025_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/viro.2000.0203","article-title":"Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes","volume":"15","author":"Drillien","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2008.03.025_bib14","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.48.11.4154-4162.2004","article-title":"Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity","volume":"48","author":"Herget","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2008.03.025_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(93)90012-V","article-title":"A new approach for measurement of cytotoxicity using colorimetric assay","volume":"15","author":"Hussain","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2008.03.025_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2008.03.025_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2008.03.025_bib18","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1128\/JCM.43.10.5003-5008.2005","article-title":"Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir","volume":"43","author":"Lee","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2008.03.025_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-83-5-1013","article-title":"Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy","volume":"83","author":"Marschall","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2005.00035.x","article-title":"Postherpetic neuralgia: the never-ending challenge","volume":"5","author":"Niv","year":"2005","journal-title":"Pain Pract."},{"key":"10.1016\/j.jviromet.2008.03.025_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1208\/aapsj070109","article-title":"bDNA-based therapeutics and DNA delivery systems: a comprehensive review","volume":"7","author":"Patil","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.jviromet.2008.03.025_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tmrv.2006.08.005","article-title":"Transfusion-transmitted cytomegalovirus: lessons from a murine model","volume":"21","author":"Roback","year":"2007","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.jviromet.2008.03.025_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1386-6532(01)00221-9","article-title":"Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility","volume":"23","author":"Sarisky","year":"2002","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0166-3542(02)00074-8","article-title":"2-Chloro-3-pyridin-3yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections","volume":"55","author":"Snoeck","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2008.03.025_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nbt1187","article-title":"An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly","volume":"24","author":"Stray","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2008.03.025_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.micinf.2004.01.011","article-title":"Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes","volume":"6","author":"Tanaka","year":"2004","journal-title":"Microb. Infect."},{"key":"10.1016\/j.jviromet.2008.03.025_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"5","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2008.03.025_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00000441-200106000-00003","article-title":"Zoster in patients infected with HIV: a review","volume":"321","author":"Vafai","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jviromet.2008.03.025_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/AAC.49.2.656-662.2005","article-title":"Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro","volume":"49","author":"Wan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2008.03.025_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jviromet.2004.05.010","article-title":"Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein","volume":"120","author":"Wang","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2008.03.025_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2008.03.025_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/viro.2000.0304","article-title":"Varicella-zoster virus infection of a human CD4-positive T-cell line","volume":"10","author":"Zerboni","year":"2000","journal-title":"Virology"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093408001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093408001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T21:22:42Z","timestamp":1588713762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093408001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0166093408001213"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2008.03.025","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}